Identification and validation of NOLC1 as a potential target for enhancing sensitivity in multidrug resistant non-small cell lung cancer cells

Adjuvant chemotherapy has become the frequently adopted standard therapeutic approach for non-small cell lung cancer (NSCLC). However, the development of multidrug resistance (MDR) is a major obstacle contributing to the failure of chemotherapy. This study aimed to identify genes associated with MDR...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Mol Biol Lett
Main Authors: Huang, Huaping, Li, Tangying, Chen, Mingjing, Liu, Feng, Wu, Haifeng, Wang, Jie, Chen, Jialiang, Li, Xi
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6258490/
https://ncbi.nlm.nih.gov/pubmed/30505321
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s11658-018-0119-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados